サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356799

中咽頭がんの診断と治療薬市場レポート：2030年までの動向、予測、競合分析

Oropharyngeal Cancer Diagnosis and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

中咽頭がんの診断と治療薬市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

口腔咽頭がんの診断と治療薬の動向と予測

世界の口腔咽頭がん診断・治療市場は、2024年から2030年までのCAGRが9.2%で、2030年までに推定33億米ドルに達すると予測されます。この市場の主な促進要因は、中咽頭がんの罹患率の上昇、タバコとアルコールの大量消費、ヒトパピローマウイルス（hpv）感染の増加です。世界の中咽頭がん診断・治療薬市場の将来は、病院と外来手術センター市場でのビジネスチャンスにより有望視されています。

中咽頭がん診断・治療薬市場の洞察

Lucintelは、CTスキャンが予測期間中に最も高い成長を遂げると予測しています。

病院は、中咽頭がんの診断と治療の主要施設として機能し、これらの重要なサービスを提供するために必要不可欠なインフラと専門的な専門知識を有しているため、最大のセグメントであり続けるでしょう。

アジア太平洋は、口腔咽頭がん患者の増加と口腔咽頭に対する意識の高まりにより、予測期間中に最も高い成長を遂げると予想されます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.今後成長が加速するセグメントとその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の中咽頭がんの診断および治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の中咽頭がんの診断および治療市場動向（2018～2023年）および予測（2024～2030年）
  • 種類別の世界の中咽頭がんの診断および治療市場
    • 内視鏡検査
    • 生検
    • イメージング
    • MRIスキャン
    • CTスキャン
    • ペットCTスキャン
  • 治療別の世界の中咽頭がんの診断および治療市場
    • 手術
    • 化学療法
    • 放射線治療
    • 標的療法
    • その他
  • 最終用途別の世界の中咽頭がんの診断および治療市場
    • 病院
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の中咽頭がんの診断および治療市場
  • 北米の中咽頭がんの診断および治療市場
  • 欧州の中咽頭がんの診断および治療市場
  • アジア太平洋中咽頭がんの診断および治療市場
  • その他地域中咽頭がんの診断および治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の中咽頭がんの診断および治療市場の成長機会
    • 治療別の世界の中咽頭がん診断および治療市場の成長機会
    • 最終用途別の世界の中咽頭がん診断および治療市場の成長機会
    • 地域別の世界の中咽頭がん診断および治療市場の成長機会
  • 世界の中咽頭がんの診断および治療市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の中咽頭がん診断・治療市場の能力拡大
    • 世界の中咽頭がんの診断および治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck
目次

Oropharyngeal Cancer Diagnosis and Therapeutics Trends and Forecast

The future of the global oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption ,and rise in human papillomavirus (hpv) infections.

A more than 150-page report is developed to help in your business decisions.

Oropharyngeal Cancer Diagnosis and Therapeutics by Segment

The study includes a forecast for the global oropharyngeal cancer diagnosis and therapeutics by type, treatment, end use, and region.

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Endoscopy
  • Biopsy
  • Imaging
  • MRI Scan
  • CT Scan
  • Pet-CT Scan

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oropharyngeal Cancer Diagnosis and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oropharyngeal cancer diagnosis and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oropharyngeal cancer diagnosis and therapeutics companies profiled in this report include-

  • Ab Sciences
  • Advaxis
  • Astrazeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • Ge Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Oropharyngeal Cancer Diagnosis and Therapeutics Market Insights

Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Hospitals will remain the largest segment as it serves as the primary facilities for diagnosing and treating oropharyngeal cancer and possess the essential infrastructure and specialized expertise required to deliver these crucial services.

APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Features of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market

Market Size Estimates: Oropharyngeal cancer diagnosis and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Oropharyngeal cancer diagnosis and therapeutics market size by type, treatment, end use, and region. in terms of value ($B).

Regional Analysis: Oropharyngeal cancer diagnosis and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatments , end uses, and region.s for the oropharyngeal cancer diagnosis and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oropharyngeal cancer diagnosis and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the oropharyngeal cancer diagnosis and therapeutics market size?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030.

Q.2. What is the growth forecast for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to grow with a CAGR of 9.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the oropharyngeal cancer diagnosis and therapeutics market?

Answer: The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption, and rise in human papillomavirus (HPV) infections.

Q.4. What are the major segments for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The future of the oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q.5. Who are the key oropharyngeal cancer diagnosis and therapeutics market companies?

Answer: Some of the key oropharyngeal cancer diagnosis and therapeutics companies are as follows:

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Q.6. Which oropharyngeal cancer diagnosis and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Q.7. In oropharyngeal cancer diagnosis and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oropharyngeal cancer diagnosis and therapeutics market by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), end use (hospitals, ambulatory surgery centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 3.3.1: Endoscopy
    • 3.3.2: Biopsy
    • 3.3.3: Imaging
    • 3.3.4: MRI Scan
    • 3.3.5: CT Scan
    • 3.3.6: Pet-CT Scan
  • 3.4: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 3.4.1: Surgery
    • 3.4.2: Chemotherapy
    • 3.4.3: Radiation Therapy
    • 3.4.4: Targeted Therapy
    • 3.4.5: Others
  • 3.5: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgery Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 4.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.2.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.3: European Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.3.1: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.3.2: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.4.1: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.4.2: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.5.1: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.5.2: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ab Sciences
  • 7.2: Advaxis
  • 7.3: AstraZeneca
  • 7.4: Bayer
  • 7.5: Boston Biomedical
  • 7.6: Bristol-Myers Squibb
  • 7.7: GE Healthcare
  • 7.8: Immunovaccine
  • 7.9: Inovio Pharmaceuticals
  • 7.10: Merck